Testing helps establish a final diagnosis and follow-up care options in the following situations:
- Poorly differentiated tumors
- New primary vs. recurrence
- Unusual presentation
CancerTYPE ID® is performed and billed separately by NeoGenomics’ contracted reference laboratory, Biotheranostics, Inc., an independent CLIA-licensed and CAP-accredited reference laboratory. CancerTYPE ID® may be ordered as a stand-alone test directly from Biotheranostics, Inc. a Hologic Company. Please see www.cancertypeid.com.
Pairing of Classifications with Tumor Profiles
When CancerTYPE ID® and NeoTYPE® Cancer Profiles are ordered together, the NeoTYPE® profile performed will be based on the CancerTYPE ID® result as shown in the table below. If Neo Comprehensive – Solid Tumor is the preferred and ordered test, Neo Comprehensive – Solid Tumor will be performed instead of a NeoTYPE® profile (for non-New York).
NeoGenomics prides itself on our unparalleled customer support team. If you have questions regarding test information, specimen requirements, turnaround times, test add-on, and patient results, please feel free to reach out to a Client Services Advocate at email@example.com
Find printable ordering information as well as specimen requirements here.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients